Activation of supraspinal gamma-aminobutyric acid-A (GABA(A)) receptor
s is known to result in antagonism of opioid analgesia. Since benzodia
zepines enhance the action of GABA at GABA(A) receptors, we hypothesiz
ed that administration of these agents for preoperative sedation might
antagonize the analgesic effects of opioids administered postoperativ
ely. If so, then administration of the benzodiazepine antagonist fluma
zenil should enhance postoperative morphine analgesia. In a double-bli
nd, placebo-controlled study of patients who received a preoperatively
administered benzodiazepine (diazepam) for sedation and a postoperati
vely administered opioid (morphine) for analgesia, we investigated opi
oid-benzodiazepine interactions affecting postoperative dental pain, W
e found that flumazenil significantly enhanced morphine analgesia cons
istent with the hypothesis that the preoperatively administered benzod
iazepine exerts an ongoing antianalgesic effect. In addition, we follo
wed these patients over the first and second postoperative days to det
ermine if there were differences between the drug groups in post-disch
arge pain, analgesic consumption, or side-effects. Participants receiv
ing flumazenil reported significantly less post-discharge nausea and u
sed significantly less ibuprofen. Since post-discharge pain levels wer
e nor significantly different, these results suggest that the patients
receiving flumazenil required less analgesic medication to achieve a
comparable level of pain control. In summary, our results indicate tha
t the benzodiazepine antagonist flumazenil enhances morphine analgesia
and decreases post-discharge side-effects as well as post-discharge n
eed for analgesic medication. (C) 1997 International Association for t
he Study of Pain.